candesartan cilexetil has been researched along with Injury, Myocardial Reperfusion in 2 studies
candesartan cilexetil: a prodrug which is metabolized to an active form candesartan to exert its biological effects
| Excerpt | Relevance | Reference |
|---|---|---|
| "We investigated the protective effect of angiotensin II (Ang II) type 1 receptor antagonist on myocardial ischemia-reperfusion injury and the role of exogenous Ang II to this injury in perfused hearts." | 3.69 | Cardioprotective effect of the angiotensin II type 1 receptor antagonist TCV-116 on ischemia-reperfusion injury. ( Akioka, K; Kim, S; Omura, T; Takeuchi, K; Tani, T; Teragaki, M; Toda, I; Yamagishi, H; Yanagi, S; Yoshiyama, M, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yoshiyama, M | 1 |
| Kim, S | 1 |
| Yamagishi, H | 1 |
| Omura, T | 1 |
| Tani, T | 1 |
| Yanagi, S | 1 |
| Toda, I | 1 |
| Teragaki, M | 1 |
| Akioka, K | 1 |
| Takeuchi, K | 1 |
| Jalowy, A | 1 |
| Schulz, R | 1 |
| Heusch, G | 1 |
1 review available for candesartan cilexetil and Injury, Myocardial Reperfusion
| Article | Year |
|---|---|
AT1 receptor blockade in experimental myocardial ischemia/reperfusion.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Arrhythmias, Ca | 1999 |
1 other study available for candesartan cilexetil and Injury, Myocardial Reperfusion
| Article | Year |
|---|---|
Cardioprotective effect of the angiotensin II type 1 receptor antagonist TCV-116 on ischemia-reperfusion injury.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; | 1994 |